Perseon Corp (NASDAQ:PRSN)

0.33
Delayed Data
As of May 22
 +0.0109 / +3.42%
Today’s Change
0.19
Today|||52-Week Range
1.19
-7.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$13.3M

Company Description

Perseon Corp. develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies. Its product line for cancer therapy has been created to offer hospitals and clinics a complete solution for thermal treatment of certain cancers as provided through microwave/RF systems. The company's product line includes a range of thermal systems for the treatment of certain cancers, including both hyperthermia and ablation treatment systems. Its hyperthermia cancer treatment systems are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. Its microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. The company was founded on March 17, 1978 and is headquartered in Salt Lake City, UT.

Contact Information

Perseon Corp.
2188 West 2200 South
Salt Lake City Utah 84119
P:(801) 972-5555
Investor Relations:
18019725555219

Employees

Shareholders

Mutual fund holders2.57%
Individual stakeholders18.90%
Other institutional1.86%

Top Executives

Clint CarnellPresident, Chief Executive Officer & Director
William S. BarthCFO, Secretary & Head-Investor Relations
Paul F. TurnerChief Technology Officer & Senior Vice President
Todd H. TurnlundVice President-Research & Development
Brian MeltzerChief Medical Officer & VP-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account